EPREX-10000 IU
7,300.00৳
- Size Guide
Size Guide
DRESSEST-SHIRTBOTTOMSDRESSESSize Chest Waist Hips XS 34 28 34 S 36 30 36 M 38 32 38 L 40 34 40 XL 42 36 42 2XL 44 38 44 All measurements are in INCHES
and may vary a half inch in either direction.
T-SHIRTSize Chest Waist Hips 2XS 32 26 32 XS 34 28 34 S 36 30 36 M 38 32 38 L 40 34 40 XL 42 36 42 All measurements are in INCHES
and may vary a half inch in either direction.
BOTTOMSSize Chest Waist Hips XS 34 28 34 S 36 30 36 M 38 32 38 L 40 34 40 XL 42 36 42 2XL 44 38 44 All measurements are in INCHES
and may vary a half inch in either direction.
- Delivery & Return
Delivery
Store delivery FREE
1-3 working days
Home or collection point from £35.00 FREE
On all your orders for home or collection point delivery
Returns
Return
We will accept exchanges and returns of unworn and unwashed garments within 30 days of the date of purchase (14 days during the sales period).
Returns in store FREE
Your return will usually be processed within a week to a week and a half. We’ll send you a Return Notification email to notify you once the return has been completed. Please allow 1-3 business days for refunds to be received to the original form of payment once the return has been processed.
- Ask a Question
Medicine Overview of Eprex 4000IU Injection
Eprex is a medicine that helps your bone marrow to produce more red blood cells. It is used to treat a type of anemia caused by kidney disease. It is also used to treat anemia caused by cancer chemotherapy and by taking medicines to treat HIV.
Eprex is given by injection either under the skin or into a vein which will be decided by your doctor. Usually the injections are given by a nurse or doctor. The dose depends on your body weight and the cause of your anemia. Iron supplements both before and during treatment may make this treatment more effective. Eprex needs to be stored in a fridge but used at room temperature.
The most common side effects of taking this medicine include nausea, vomiting and increased blood pressure. It may also cause flu-like symptoms such as headache, tiredness, dizziness and aches and pains. These side effects are most common at the start of treatment but if they persist your doctor may be able to suggest ways of preventing or reducing them. Tell your doctor straight away if you get any serious side effects, including seizures (fits). Sometimes this medicine can cause serious blood clots which need urgent medical attention.
Before using Eprex you should tell your doctor if you have uncontrolled high blood pressure, heart disease or gout (disease of joint pain). You should also tell him/her what other medicines you are taking in case they affect this treatment. Your blood pressure should be checked often during this treatment by you or your doctor. You may also need other regular medical tests to be sure this medicine is not causing harmful effects. It is not known whether this medicine will harm an unborn baby. Tell your doctor if you are pregnant, plan to become pregnant or are breastfeeding.
- Anemia due to chronic kidney disease
- Anemia due to cancer chemotherapy
- High blood pressure
- Nausea
- Fever
- Vomiting
-
Eprex helps in the treatment of anemia that may have occurred due to chronic kidney disease or cancer chemotherapy.
-
It is given as a single injection under your skin.
-
Your doctor may get your blood tests done regularly to monitor the levels of hemoglobin, blood cells and electrolytes such as potassium in your blood.
-
Monitor your blood pressure regularly while taking this medication. Inform your doctor if you notice symptoms of very high blood pressure such as severe headache, problems with your eyesight, nausea, vomiting or fits (seizures).
-
Stop taking Eprex and inform your doctor if you develop shortness of breath or skin rash.
Reduction of need for red blood cell (RBC) transfusion in patients with chronic kidney disease (CKD)
Patient not on dialysis: 50-100 units/kg IV/SC 3 times weekly initiallyInitiate only when (1) hemoglobin level <10 g/dL, (2) rate of hemoglobin decline indicates likely necessity of RBC transfusion, and (3) reducing risk of alloimmunization or other risks related to RBC transfusion is goal; if hemoglobin level >10 g/dL, reduce or interrupt dose and use lowest dose sufficient to reduce need for RBC transfusion
Patient on dialysis: 50-100 units/kg IV 3 times weekly initially
Initiate when hemoglobin level <10 g/dL; if hemoglobin level approaches or exceeds 11 g/dL, reduce or interrupt dose
Zidovudine-Related Anemia
Treatment of anemia due to zidovudine administered at <4200 mg/week in HIV-infected patients with endogenous serum erythropoietin levels of <500 milliunits/mL
100 units/kg IV/SC 3 times weekly initially
Chemotherapy-Related Anemia
Treatment of anemia in patients with nonmyeloid malignancies where anemia is due to effect of concomitant myelosuppressive chemotherapy for >2 months
150 units/kg IV/SC 3 times weekly initially; alternatively, 40,000 units SC once weekly until completion of chemotherapy course
Preparation for Surgery With High Risk of Blood Loss
Reduction of need for allogeneic RBC transfusions in patients with perioperative hemoglobin >10 g/dL but ?13 g/dL who are at high risk for perioperative blood loss from elective, noncardiac, nonvascular surgery
300 units/kg SC once daily for 15 consecutive days (10 days preceding surgery, day of surgery, 4 days following surgery); alternatively, 600 units/kg SC in 4 doses administered 21, 14, and 7 days before surgery and on day of surgery
<1 month: Safety and efficacy not established
>1 month: 50 units/kg IV/SC 3 times weekly initially; if patient on dialysis, IV route recommendedInitiate when hemoglobin level <10 g/dL; if hemoglobin level approaches or exceeds 11 g/dL, reduce or interrupt dose
Prematurity-Related Anemia
25-100 units/kg SC 3 times weekly or 200-400 units/kg SC/IV q24-48hr for 2-6 weeks
Zidovudine-Related Anemia
<8 months: Safety and efficacy not established
8 months-17 years: 50-400 units/kg SC/IV 2-3 times weekly
Chemotherapy-Related Anemia
<5 years: Safety and efficacy not established
5-18 years: 600 units/kg IV once weekly; not to exceed 40,000 units
Hypertension; history of seizures; thrombocytosis; chronic liver failure; poor renal function; ischaemic vascular disease; malignant tumours. Increased risk of thrombotic events. Monitor BP during treatment. Regularly monitor platelet counts and serum-potassium concentration. Iron deficiency, infection or inflammatory disorders, haemolysis, or aluminium intoxication will reduce efficacy. Proper dosage control is required to prevent to rapid increase in the haematocrit and haemoglobin levels. Pregnancy; lactation.
Lactation: Unknown whether drug is excreted in breast milk; use with caution; avoid administering multidose vials
Pyrexia (10-42%),Nausea (11-35%),Hypertension (14-27%),Cough (4-26%),Vomiting (12-28%),Pruritus (12-21%),Rash (2-19%),Headache (5-18%),Arthralgias (10-16%)1-10%
Arthralgia (10%),Myalgia (10%),Stomatitis (10%),Diarrhea (9%),Dizziness (9%),Edema (9%),Fatigue (9%),Weight decrease (9%),Medical device malfunction (artificial kidney clotting during dialysis) (8%),Vascular occlusion (vascular access thrombosis) (8%),Vomiting (8%),Asthenia (7%),Chest pain (7%),Injection-site irritation (7%),Muscle spasm (7%),Upper respiratory tract infection (URTI) (7%),Urticaria (3%),Seizures (2.5%),Pulmonary embolism (1%),Respiratory tract congestion (1%)
Limited data available on epoetin alfa use in pregnant women are insufficient to determine a drug-associated risk of adverse developmental outcomesAnimal data
In animal reproductive and developmental toxicity studies, adverse fetal effects including embryo-fetal death, skeletal anomalies, and growth defects occurred when pregnant rats received epoetin alfa at doses approximating the clinical recommended starting doses
Consider the benefits and risks of epoetin alfa for the mother and possible risks to the fetus when prescribing epoetin alfa to a pregnant woman
Lactation
There is no information regarding the presence of epoetin alfa products in human milk, the effects on the breastfed infant, or the effects on milk production
However, endogenous erythropoietin is present in human milk
Because many drugs are present in human milk, exercise caution when epoetin alfa is administered to a lactating woman
Cyclosporine, hematinic agents, drugs that decrease erythropoiesis. Potentiated by hematinic agents.
‘
5 |
|
0 |
4 |
|
0 |
3 |
|
0 |
2 |
|
0 |
1 |
|
0 |
- Vaccines
- Face Wash
- Anti-Arrhythmic
- Cream & Moisturizer
- Hair Care
- Anti Hairfall Shampoos
- Medicated Shampoos
- Anti Dandruff Shampoos
- Clarifying Shampoos
- Hairstyling Products
- Natural & Organic Shampoos
- Hair Gels
- Dry Shampoos
- Hair Sprays
- Volumizing Shampoos
- Shampoo
- Moisturizing Shampoos
- Curl Enhancing Shampoos
- Daily Shampoos
- Smoothing & Frizz Control Shampoos
- Repairing Shampoos
- Strengthening Shampoos
- Hair Growth Shampoo
- Sulfate Free Shampoos
- Scalp Healing Shampoos
- Colour Protecting Shampoos
- Anti-Aging Products
- Anti-Hypertensive
- Sexual Wellness
- Barrier Repair Cream
- Gastrointestinal System
- Anti-Wrinkle Creams & Serums
- Beta-Blockers
- Harbal
- Hydrating Moisturizer
- Genitourinary System
- Cardiac
- Anti-Ischaemic
- Miscellaneous Topical Agents
- Skincare
- Hepatic viral infections (Hepatitis B)
- Congestive Heart Failure
- Beauty
- Skin Care
- Diabetes Care
- Day Creams
- Supplements
- Food
- Anti-diarrhoeal Antiprotozoal
- Lipid Regulation
- Body Lotion & Cream
- ppi
- Amoebicides
- Calcium-Channel Blockers
- Medicine
- Nasal Preparations
- Central Nervous System
- Cardiovascular System
- Chemotherapy & Immunosuppressants
- Anemia & Other Blood Disorders
- Genitourinary System
- Musculoskeletal Systems
- Antimicrobial
- Vitamin, Mineral & Nutritional Deficiency
- Urinary System
- Endocrine & Metabolic System
- CNS System
- Dermatological Preparations
- Anti-Bacterial
- OTC Medicine
- Analgesic & Antipyretic
- Anesthetics & Neuromuscular Blocking
- Gastrointestinal System
- E.N.T Preparations
- Bone Formation & Disorders
- Mouth & Throat
- Respiratory System
- Aural Preparations
- Cerebrovascular System
- Allergy & Immune System
- BIODERMA
- Emergency Contraceptive Pill
- Haemostatic drugs
- Health Care
- Baby And MoM
- Anti-Coagulants
- Soaps
- Oral Nutritions
- Oral nutritional preparations
- Intestinal Secretions
- Cleansers & Bodywash
- MOUTH CARE
- Cardiovascular System
- Veterinary and Pet Care
- General Anesthesia
- Shampoo & Conditioners
- Ischemic Stroke
Reviews
There are no reviews yet.